US commission urges action to keep biotech advantage over China
The report contains a raft of measures that Congress could enact to “leverage our capital markets to advance national biotechnology priorities.” These ...
Read the original at Fierce Biotech ↗
- Topics
- China & GeopoliticsRegulation & Policy
- Mentions
- ChinaCongress
- Tracked via
- “chinese ai advances”